Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Clinical Cardiology
|
May 21, 2009
Propionibacterium acnes endocarditis of a prosthetic aortic valve
Richard J List, Nabeel Sheikh, Thomas Theologou, et al.
The Biochemical Journal
|
November 1, 1978
Enhancement of the viscosity of mucin by serum albumin
S J List, B P Findlay, G G Forstner, et al.
Experimental Cell Research
|
April 2, 1998
Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome
M T Bonovich, H J List, S Zhang, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2013
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
H J Lambers Heerspink, D de Zeeuw, L Wie, et al.
Current Medical Research and Opinion
|
August 5, 2009
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
J Rosenstock, C Aguilar-Salinas, E Klein, et al.
Vox Sanguinis
|
September 20, 2011
The effect of plasma removal from apheresis platelet concentrates on platelet function
P Jilma-Stohlawetz, B Eichelberger, J List, et al.
Experimental Cell Research
|
October 21, 1999
Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter
H J List, C L Smith, O Rodriguez, et al.
The Journal of Biological Chemistry
|
June 29, 2000
Mitogen-induced expression of the fibroblast growth factor-binding protein is transcriptionally repressed through a non-canonical E-box element
V K Harris, C M Coticchia, H J List, et al.
International Journal of Clinical Practice
|
July 21, 2009
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
A R Chacra, G H Tan, A Apanovitch, et al.
Vox Sanguinis
|
January 12, 2010
Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use
G C Leitner, M Dettke, J List, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Clinical Cardiology
|
May 21, 2009
Propionibacterium acnes endocarditis of a prosthetic aortic valve
Richard J List, Nabeel Sheikh, Thomas Theologou, et al.
The Biochemical Journal
|
November 1, 1978
Enhancement of the viscosity of mucin by serum albumin
S J List, B P Findlay, G G Forstner, et al.
Experimental Cell Research
|
April 2, 1998
Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome
M T Bonovich, H J List, S Zhang, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2013
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
H J Lambers Heerspink, D de Zeeuw, L Wie, et al.
Current Medical Research and Opinion
|
August 5, 2009
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
J Rosenstock, C Aguilar-Salinas, E Klein, et al.
Vox Sanguinis
|
September 20, 2011
The effect of plasma removal from apheresis platelet concentrates on platelet function
P Jilma-Stohlawetz, B Eichelberger, J List, et al.
Experimental Cell Research
|
October 21, 1999
Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter
H J List, C L Smith, O Rodriguez, et al.
The Journal of Biological Chemistry
|
June 29, 2000
Mitogen-induced expression of the fibroblast growth factor-binding protein is transcriptionally repressed through a non-canonical E-box element
V K Harris, C M Coticchia, H J List, et al.
International Journal of Clinical Practice
|
July 21, 2009
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
A R Chacra, G H Tan, A Apanovitch, et al.
Vox Sanguinis
|
January 12, 2010
Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use
G C Leitner, M Dettke, J List, et al.
Page
of 7